When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AZRX - AzurRx up 7% in inclusion of TDN sites in cystic fibrosis study
AzurRx BioPharma Inc.
AzurRx BioPharma (AZRX+7.3%) announces that it will conduct its Phase 2 clinical trial, OPTION 2, evaluating lead candidate MS1819 in cystic fibrosis (CF) patients with exocrine pancreatic insufficiency in Therapeutics Development Network (TDN) sites.
More news on: AzurRx BioPharma, Inc., Healthcare stocks news, Stocks on the move,